Skip to main content

Mitesco to Host Shareholder Update Webcast/Conference Call March 8 at 4:15 p.m. Eastern

MINNEAPOLIS, MN, March 03, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Mitesco, Inc. (OTCQB: MITI), a leading operator of wellness clinics that combine a nurse practitioner model with personalized, whole-person primary care, will host a shareholder update conference call Tuesday, March 8, 2022, at 4:15 p.m. Eastern Time. The call, which will feature a presentation by CEO Larry Diamond of the company’s newly updated investor PowerPoint, will include a discussion of Mitesco’s significant progress on its expansion plans, plans to uplist the company’s common stock to Nasdaq, growth in the activity level of its existing clinics, and other developments. The presentation will be followed by a question-and-answer session, which can be accessed via the webcast link or dial-in numbers below.

To view the PowerPoint and presentation and participate live over the webcast link, please go to: https://www.webcaster4.com/Webcast/Page/2848/44800

If unable to view the webcast, you may participate via teleconference by dialing in five to ten minutes before the call: (Toll Free) 888-506-0062 domestically, or 973-528-0011 internationally. Entry code: 264574.

The teleconference replay will be available shortly after the completion of the live event through 4:15 p.m. Eastern time on March 22, 2022. You may access the replay by dialing (Toll Free) 877-481-4010 domestically, or 919-882-2331 internationally, and referencing conference ID 44800.

You may also access the replay by visiting the company’s website: www.mitescoinc.com. The site also includes a company overview, links to research, video interviews with management, and contact information.

“There is a Form S-1A Registration Statement filed and available for review on the SEC Edgar website (https://www.sec.gov/ixdoc=/Archives/edgar/data/802257/000118518522000159/miti-20210930.htm), and I encourage all interested parties to review the information prior to this call,” said Mr. Diamond. “Further, we will be attending a number of investor conferences in the near-term, and through press releases will continue to update our shareholders on new developments as they occur.” 

About Mitesco, Inc. and The Good Clinic, LLC

Mitesco is building a next-generation healthcare solution, providing healthcare services and technology, to make healthcare more accessible, higher quality, and more affordable. The Mitesco team has extensive experience in building successful growth situations within the healthcare industry, using both organic and acquisition growth strategies. Mitesco embraces that when consumers’ expectations are exceeded the business performance does so as well. Mitesco operations and subsidiaries include The Good Clinic, LLC (“The Good Clinic”) and Acelerar Healthcare Holdings Limited. The Good Clinic (www.thegoodclinic.com) is a wholly owned subsidiary of Mitesco N.A. LLC, the holding company for North American operations. The Good Clinic is building out a network of clinics using the latest telehealth technology with the certified nurse practitioner operating as its primary healthcare provider. The executive team at The Good Clinic includes several of the key executives who brought Minute ClinicTM (previously known as Quickmedix) to scale, which was acquired by CVS in 2006.

Contacts:

Investor Relations
Jimmy Caplan
512-329-9505
Email: jimmycaplan@me.com

Media Relations
Rick Eisenberg
917-691-8934
Email: eiscom@msn.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.